Webinar Recording: How to Design for an Unmet Need

Adopting breakthrough health technologies is never easy, especially when they reshape how clinicians and patients interact outside traditional settings. In this on-demand webinar, Ilsa Webeck of Simbex and Claire Dixon, CEO of Neuraura, unpack the journey from invasive neurotech to an AI-first bio-wearable for managing polycystic ovary syndrome (PCOS). Discover how design, data, and digital platforms converge to deliver accessible, at-home therapeutic solutions.

Featuring Insights From:

Ilsa Webeck, VPA, Commercialization & Marketing, Simbex
Claire Dixon, CEO, Neuraura

What You’ll Take Away:

Understanding the Unmet Need in PCOS

PCOS affects up to 20% of women assigned female at birth, yet 70% remain undiagnosed. Beyond infertility, it drives lifelong risks like insulin resistance, cardiovascular disease, mental-health challenges, and certain cancers. Learn why Claire pivoted Neuraura’s focus toward this vast, underserved population and how closing the diagnostic gap informs product design.

From Invasive Neurotech to Bio-Wearables

Trace Neuraura’s evolution from a brain-machine interface to a minimally invasive, AI-powered bio-wearable. Discover the “bio-wearable” concept, active neuromodulation in a user-friendly device, and how proven clinical pathways (like tibial nerve stimulation) inspired a direct-to-consumer model.

Integrating Device and Digital Platform for Holistic Care

See how Neuraura combines percutaneous electrodes with a rich digital ecosystem (content, community, insights, and marketplace). Understand the dual-entry model: 1) Standalone device use, and 2) A subscription-based app that guides phenotype-specific lifestyle, symptom tracking, and one-on-one chatbot support.

Commercializing Accessible Therapeutics

Explore Neuraura’s regulatory and reimbursement roadmap:

FDA Clearance: TENS-based pain-management coding for initial launch
De Novo Pathway: Claims for hormonal and metabolic regulation
Business Model: $200–$250 device; $5/mo digital subscription; FSA/HSA eligible

Learn how direct-to-consumer, prescription-free access positions this solution for rapid adoption.

Watch the Webinar On-Demand

Whether you’re evaluating bio-wearables for your clinic or designing the next wave of women’s health innovations, this session delivers actionable insights from leaders shaping the future of at-home care.